Xiaopeng Chen

786 total citations
49 papers, 582 citations indexed

About

Xiaopeng Chen is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Xiaopeng Chen has authored 49 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 18 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Xiaopeng Chen's work include Glycosylation and Glycoproteins Research (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Proteoglycans and glycosaminoglycans research (7 papers). Xiaopeng Chen is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Proteoglycans and glycosaminoglycans research (7 papers). Xiaopeng Chen collaborates with scholars based in China, United States and Saudi Arabia. Xiaopeng Chen's co-authors include Xuesong Li, Liqun Zhou, Zhisong He, Dong Fang, Gengyan Xiong, Lei Zhang, Shu-you Peng, Liubin Shi, Lin Yao and Pamela J. Lein and has published in prestigious journals such as Journal of Biomechanics, Lab on a Chip and Carcinogenesis.

In The Last Decade

Xiaopeng Chen

42 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaopeng Chen China 14 286 161 154 99 65 49 582
Shaobin Ni China 13 205 0.7× 204 1.3× 196 1.3× 88 0.9× 145 2.2× 22 603
Shuya Hirao Japan 12 148 0.5× 109 0.7× 426 2.8× 168 1.7× 124 1.9× 24 689
N Lagarde France 11 107 0.4× 144 0.9× 139 0.9× 253 2.6× 169 2.6× 28 673
Charlotta Ryk Sweden 14 206 0.7× 81 0.5× 407 2.6× 140 1.4× 109 1.7× 20 734
Eiichiro Hirakawa Japan 13 145 0.5× 76 0.5× 108 0.7× 100 1.0× 27 0.4× 53 408
Jian Pan China 13 231 0.8× 338 2.1× 214 1.4× 176 1.8× 111 1.7× 52 836
Jose R. Ramı́rez Spain 12 82 0.3× 145 0.9× 283 1.8× 91 0.9× 87 1.3× 13 580
Takeshi Hirao Japan 13 101 0.4× 175 1.1× 248 1.6× 126 1.3× 68 1.0× 23 534
K Isono Japan 15 193 0.7× 127 0.8× 224 1.5× 145 1.5× 44 0.7× 60 611
C. Gil Restrepo United States 7 116 0.4× 65 0.4× 157 1.0× 194 2.0× 55 0.8× 7 453

Countries citing papers authored by Xiaopeng Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaopeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Chen more than expected).

Fields of papers citing papers by Xiaopeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaopeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Chen. The network helps show where Xiaopeng Chen may publish in the future.

Co-authorship network of co-authors of Xiaopeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaopeng Chen. A scholar is included among the top collaborators of Xiaopeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaopeng Chen. Xiaopeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaoxin, et al.. (2025). Potential Roles of Serum Exosomal CD155 and its Impact on NK Cell Immunosuppression in Hepatocellular Carcinoma. Balkan Medical Journal. 42(3). 242–253. 1 indexed citations
2.
Zhang, Wenjun, et al.. (2025). Targeting DUSP3 promotes cell senescence by activating the notch1 pathway to treat hepatocellular carcinoma. Tissue and Cell. 94. 102781–102781. 1 indexed citations
3.
4.
Chen, Bin, Luz Angela Torres-de la Roche, Guilin Wang, et al.. (2024). Ultrasound Genomics Reveals a Signature for Predicting Breast Cancer Prognosis and Therapy Response. Cancer Biotherapy and Radiopharmaceuticals. 40(1). 54–61.
5.
Chen, Xiaopeng, et al.. (2024). Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma. Frontiers in Oncology. 14. 1301059–1301059.
6.
Chen, Baorong, Bangyu Wang, Xiaopeng Chen, et al.. (2023). Upregulation of NUAK2: A novel prognostic marker in breast cancer.. PubMed. 38(7). 811–822. 4 indexed citations
7.
Chen, Xiaopeng, Xiaowei Zhang, Yitong Jiang, et al.. (2022). YAP1 activation promotes epithelial–mesenchymal transition and cell survival of renal cell carcinoma cells under shear stress. Carcinogenesis. 43(4). 301–310. 18 indexed citations
8.
Chen, Xiaopeng, et al.. (2022). MicroRNA-378 inhibits hepatocyte apoptosis during acute liver failure by targeting caspase-9 in mice. Gastroenterología y Hepatología. 46(2). 124–134.
9.
Chen, Xiaopeng, et al.. (2021). Deep-learning on-chip light-sheet microscopy enabling video-rate volumetric imaging of dynamic biological specimens. Lab on a Chip. 21(18). 3420–3428. 9 indexed citations
10.
Chen, Xiaopeng, et al.. (2021). Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression. BioMed Research International. 2021(1). 4051192–4051192. 6 indexed citations
11.
Chen, Xiaopeng, et al.. (2017). Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells. Journal of Cancer. 8(16). 3309–3317. 12 indexed citations
12.
Jiang, Xuemei, Xiang‐Nan Yu, Hairong Zhu, et al.. (2016). Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 142(11). 2309–2317. 25 indexed citations
13.
Fan, Wen, Huijie Zhang, Zheng Liu, et al.. (2015). Sca1+ mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation. International Immunopharmacology. 26(1). 50–57. 8 indexed citations
14.
Fang, Dong, Lei Zhang, Xuesong Li, et al.. (2014). Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center. Journal of Cancer Research and Clinical Oncology. 140(3). 477–485. 25 indexed citations
15.
Fang, Dong, Gengyan Xiong, Xuesong Li, et al.. (2014). Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urologic Oncology Seminars and Original Investigations. 33(2). 66.e1–66.e11. 17 indexed citations
16.
Ji, Zhaohua, Cuiying Li, Yonggang Lv, et al.. (2012). The prevalence and trends of transfusion-transmissible infectious pathogens among first-time, voluntary blood donors in Xi’an, China between 1999 and 2009. International Journal of Infectious Diseases. 17(4). e259–e262. 35 indexed citations
17.
Chen, Xiaopeng, et al.. (2012). Activity and tumor specificity of human heparanase gene core promoter. Molecular Medicine Reports. 6(4). 867–871. 1 indexed citations
18.
Chen, Xiaopeng, Xiaofeng Xu, Xianwei Wang, et al.. (2011). Knockdown of hTERT Alters Biophysical Properties of K562 Cells Resulting in Decreased Migration Rate In Vitro. Cell Biochemistry and Biophysics. 61(3). 595–603. 9 indexed citations
19.
Chen, Xiaopeng, Shu-you Peng, Yulian Wu, et al.. (2002). [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].. PubMed. 82(22). 1553–6. 2 indexed citations
20.
Chen, Xiaopeng. (2002). A ten-year study on non-surgical treatment of postoperative bile leakage. World Journal of Gastroenterology. 8(5). 937–937. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaobin Ni Breakdown of academic impact, for papers by Shuya Hirao Breakdown of academic impact, for papers by N Lagarde Breakdown of academic impact, for papers by Charlotta Ryk Breakdown of academic impact, for papers by Eiichiro Hirakawa Breakdown of academic impact, for papers by Jian Pan Breakdown of academic impact, for papers by Jose R. Ramı́rez Breakdown of academic impact, for papers by Takeshi Hirao Breakdown of academic impact, for papers by K Isono Breakdown of academic impact, for papers by C. Gil Restrepo
Rankless by CCL
2026